GE Healthcare FlexFactory Helps XPH Scale Up Industrialization of TCR T-Cell Immunotherapy Drugs

Guangzhou, China & Chalfont, UK — June 7, 2018 — GE Healthcare will provide Xiangxue Pharmaceutical Co., Ltd. (XPH) with a FlexFactory™ for cell therapy, a semi-automated end-to-end manufacturing platform, to help scale up, digitize and accelerate manufacturing processes for their cell therapy clinical trials and future commercialization. This project marks the first-ever application of... Read more

MilliporeSigma Brings Biotechs Closer to Drug Therapy Production and Commercialization

News Release June 5, 2018 Your Contact: Karen Tiano +1 978 495 0093 MilliporeSigma Brings Biotechs Closer to Drug Therapy Production and Commercialization Opens North America’s first BioReliance® End-to-End Biodevelopment Center to help customers with biopharmaceutical manufacturing processes Accelerates clinical development from DNA to market “Advance Biotech Grant Program” expands global biotech commitment to help... Read more

Hamilton Robotics and Waters Corporation Collaborate to Introduce STARWorks for Waters Assay Ready Workstations for Biopharmaceutical Sample Preparation Workflows

Automated, End-to-End Workflows Provide Hands-Free Convenience with Unrivaled Assay Sensitivity and Robust System Performance Reno, Nev., and Milford, Mass. (June 4, 2018) – Hamilton Robotics and Waters Corporation further extend their collaborative goal of streamlining biopharmaceutical sample preparation workflows with the launch of STARWorks for Waters. By integrating liquid handling expertise with in-depth sample preparation... Read more

New Software Toolset Advances Small Molecule Analysis

Easy-to-use software helps identify unknown compounds and extracts high-confidence understanding from complex mass spectra   SAN DIEGO, June 4, 2018 /PRNewswire/ — ASMS 2018 – Scientists working in metabolomics, pharmaceuticals, food safety, and environmental and forensic science can now use a fully integrated software toolkit to transform complex, unknown mass spectra generated from small molecule analysis into actionable data.... Read more

Waters Technologies for Food Safety, Food Authenticity and Biomedical Research at ASMS 2018

MILFORD, Mass.–(BUSINESS WIRE)– Waters (NYSE:WAT) is giving scientists attending ASMS 2018 a first look at new mass spectrometry technologies developed to serve the multi-faceted analytical requirements of food testing, university and biomedical research laboratories. The new products include a gas chromatography-mass spectrometry/mass spectrometry (GC-MS/MS) system for food safety analyses and a direct-analysis mass spectrometry system... Read more

Bruker Acquires Sierra Sensors to Expand Real-Time, Label-Free Detection Portfolio for Pharma and Biopharma Drug Discovery

HAMBURG, Germany, June 4, 2018 /PRNewswire/ — Bruker today announced that it has acquired Sierra Sensors GmbH, based in Hamburg, Germany. Financial details were not disclosed. Sierra develops and manufactures innovative analytical biosensors based on Surface Plasmon Resonance (SPR) detection. Driven by patented technologies in the areas of SPR detection and microfluidic sample delivery, Sierra instruments... Read more

Lonza and Innosieve Diagnostics Announce Exclusive Distribution Agreement for Rapid Bioburden Testing Technology

Cologne (DE) and Wageningen (NL) 04 June 2018 – Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of endotoxin products, services and software and provides pharmaceutical testing professionals with a comprehensive set of quality control (QC) tools. Under the agreement, Lonza... Read more

Mass Spectrometer System Offers Solution for Small Molecule Identification and Characterization

Mass Spectrometer System Offers Solution for Small Molecule Identification and Characterization New, easy-to-use analytical detection system extracts meaningful data quickly from acquisition to analysis SAN DIEGO, June 4, 2018 /PRNewswire/ — ASMS 2018 – Scientists can now use a powerful new system to automatically capture as much spectral information about small molecules as possible and efficiently... Read more

Phase III IMpower131 study showed Tecentriq(atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death for people with advanced squamous non-small cell lung cancer

Basel, 02 June 2018 Phase III IMpower131 study showed Tecentriq(atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death for people with advanced squamous non-small cell lung cancer Data will be featured in the ASCO press programme on Saturday 2 June and presented at ASCO on Monday 4 June Roche (SIX:... Read more

Phase III IMpower131 study showed Tecentriq(atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death for people with advanced squamous non-small cell lung cancer

Basel, 02 June 2018 Phase III IMpower131 study showed Tecentriq(atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death for people with advanced squamous non-small cell lung cancer Data will be featured in the ASCO press programme on Saturday 2 June and presented at ASCO on Monday 4 June Roche (SIX:... Read more